NCT07477912 2026-03-17
MSTH-CAR001
Minsk Scientific-Practical Center for Surgery, Transplantation and Hematology
Phase 1/2 Recruiting
Clinical Trials
15 trialsNCT07135466 2026-01-16
A Phase 1/2 Study of T-cell Expressing an Anti-CD22 Chimeric-Antigen Receptor (SHB-04-CD22) in Patients With CD22-expressing B-cell Malignancies
Sheba Medical Center
Phase 1/2 Recruiting
NCT07334431 2026-01-12
Fruquintinib Combined With Trastuzumab and XELOX as First-line Treatment in Patients With HER2-positive Advanced Gastric Cancer
Henan Cancer Hospital
Phase 1/2 Recruiting
NCT07264569 2025-12-04
Evaluate the Safety, Tolerability, Biodistribution Characteristics and Preliminary Efficacy of BioTTT001
Henan Cancer Hospital
Phase 1/2 Recruiting
NCT07136545 2025-09-10
A Phase I/II Trial of HCB101 in Combination With Pembrolizumab for Patients With Platinum-Refractory, Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (SirH&N Trial)
Taipei Veterans General Hospital, Taiwan
Phase 1/2 Recruiting
NCT06329973 2025-07-17
Fruquintinib in Combination With Sintilimab and CAPEOX as First-line Treatment for G/GEJ Cancer
Henan Cancer Hospital
Phase 1/2 Recruiting
NCT03093688 2025-07-02
Clinical Safty and Efficacy Study of Infusion of iNKT Cells and CD8+T Cells in Patients With Advanced Solid Tumor
Shanghai Public Health Clinical Center
Phase 1/2 Recruiting
NCT06880029 2025-03-19
CIRCADIAN
Centro Hospitalar de Vila Nova de Gaia/Espinho, E.P.E.
Phase 1/2 Recruiting
NCT05319639 2025-02-27
Phase I/II Study of the Combination of Irinotecan and POF (POFI) and Tislelizumab
Fujian Cancer Hospital
Phase 1/2 Recruiting
NCT06299462 2025-02-25
PTCy and ATG for MSD and MUD Transplants
Instituto Nacional de Cancer, Brazil
Phase 1/2 Recruiting
NCT05937438 2025-01-29
Postoperative Radiotherapy Followed by Immunotherapy for Locally Advanced Esophageal Carcinoma
Anhui Provincial Hospital
Phase 1/2 Recruiting
NCT05019690 2024-09-19
Apatinib Combined with Albumin-Bound Paclitaxel for Treatment of Advanced Triple Negative Breast Cancer
Fujian Cancer Hospital
Phase 1/2 Recruiting
NCT06527898 2024-09-19
Hypofractionated Radiotherapy Combined with Immunotherapy for Limited-stage Small-cell Lung Cancer
Anhui Provincial Hospital
Phase 1/2 Recruiting
NCT05269485 2024-06-25
Hypofraction Radiotherapy for Locally Advanced Non-small Cell Lung Cancer
Anhui Provincial Hospital
Phase 1/2 Recruiting
NCT03685890 2024-04-25
NivoILP
Vastra Gotaland Region
Phase 1/2 Recruiting